Ischaemic heart disease represents the most common of the serious health problems in the
contemporary society and acute myocardial infarction (AMI) is the major cause of …

According to the European Society of Cardiology, American College of Cardiology
Foundation, American Heart Association, and World Health Federation Expert consensus …

Radiolabelled anti-myosin antibodies (AM Ab) specifically accumulate in necrotizing
myocytes and, therefore, allow the scintigraphic detection of myocardial infarction. In order to …

The spectrum of unstable coronary syndromes has been the object of steadily increasing
research particularly in respect of novel diagnostic and treatment modalities. Although the …

Biochemical markers are substances that are detected in body fluids or tissues that may
signify a disease or other abnormality. Biochemical markers have been used to help in the …

This book is about new biochemical markers for the laboratory diagnosis of acute
myocardial injury. A number of new markers, such as cardiac troponin I, cardiac troponin T …

Cardiac enzymes have been in use since the mid 20th century in evaluating patients with
suspected acute myocardial infarction (MI). The biomarkers used back then are not clinically …

Myofibrillar proteins (MPs) were extracted from isolated and perfused rat hearts subjected to
different periods of ischemia to investigate the occurrence of protein degradation and/or the …

Acute myocardial infarction (AMI) is the most prevalent condition that results in sickness and
death worldwide. An early and accurate diagnosis of AMI is critical for prompt and …

1. Introduction 1950's: Clinical reports that transaminases released from dying myocytes
could be detected via laboratory testing, aiding in the diagnosis of myocardial infarction. The …